Key result
The authors question the clinical utility and safety of previously recommended rocuronium doses for electroconvulsive therapy due to unvalidated methodology and disparate recovery times.
Answers are grounded in this paper and cite their sources.
The authors question the clinical utility and safety of the previously published recommendations on neuromuscular blocker dosing for electroconvulsive therapy due to methodological concerns and disparities with published recovery times.
To the Editor We read with interest the recent recommendations of Mirzakhani et al1 on the minimum effective doses of muscle relaxants to abet electroconvulsive therapy. The authors have attempted to answer the question “how much is enough.” We think, however, that their conclusions must be read with considerable caution for the following reasons: The modification of the up and down method employed by the authors in acquiring data points within subjects has not been validated. Each patient received approximately 3 treatments with succinylcholine and 3 with rocuronium (187 treatments in 31 patients). In the Dixon’s up and down method,2,3 the sequence of eliciting positive and negative responses is repeated several times to estimate the mean and the standard error of the ED50 for each subject. The precision of the estimate is directly proportional to the sample size within each subject. Is it likely that a total of only 6 test doses will define the “optimal” dose for both drugs? The authors suggest that a rocuronium dose of 0.41 mg/kg (95% confidence limits [CL], 0.36–0.46 mg/kg) will result inadequate relaxation in 1 of 2 patients and that a dose of 0.57 mg/kg (95% CL, 0.51–0.61 mg/kg) will still produce unsatisfactory conditions 10% of the time. We find it highly unlikely that an “intubating dose” of rocuronium will fail to produce adequate conditions for electroconvulsive therapy in 1 of 10 subjects. Clearly, further clinical confirmation from other investigators would be highly desirable. The recovery times to a train-of-four ratio of 0.90 after rocuronium (19.5 ± 5.7 [standard deviation] minutes) that the authors report also need to be viewed with some skepticism. It is difficult to reconcile their observations with much of the published literature. The clinical duration (time to 25% T1 recovery) of 0.60 mg/kg rocuronium averages over 30 minutes under total intravenous anesthesia or N2O–opioid anesthesia (Table). At this level of spontaneous recovery (a train-of-four count of approximately 3), rapid antagonism of nondepolarizing residual block with neostigmine cannot be guaranteed.13–15 Available data suggest that it would be surprising if the time to satisfactory recovery after neostigmine reversal of rocuronium 0.60 mg/kg will be <35 to 40 minutes. It should be noted that the authors’ proposals were based on the criteria and observations of only 2 psychiatrists. Other clinicians may have different standards as to what constitutes an adequately modified seizure. A still unanswered question is what degree of neuromuscular block is required to prevent traumatic injury from an induced seizure. A seizure may appear quite vigorous yet still be sufficiently modified to be safe. Table.: Spontaneous Recovery Times After 0.60 and 0.40 mg/kg RocuroniumGiven our concerns regarding the authors’ methodology and the disparity between their reported recovery times with the great majority of published data regarding the duration of action of rocuronium, we question the clinical utility and safety of their recommendations. Aaron F. Kopman, MD19970 Sawgrass LaneUnit 4102Boca Raton, Florida[email protected] Mohamed Naguib, MB, BCh, MSc, FCARCSI, MDDepartment of General AnesthesiaAnesthesiology InstituteCleveland ClinicCleveland, Ohio
No takes yet. Share an insight, caveat, or question.
Kopman et al. (2016) conducted a letter in Electroconvulsive therapy (n=31). Rocuronium was evaluated. The authors question the clinical utility and safety of previously recommended rocuronium doses for electroconvulsive therapy due to unvalidated methodology and disparate recovery times.
Synapse has enriched 10 related papers. Consider them for comparative context: